Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 6,633,000 | 4,621,000 | 3,300,327 | 2,583,658 | 2,044,032 |
| Cost of Goods | 1,011,000 | 673,000 | 480,123 | 441,630 | 354,442 |
| Gross Profit | 5,622,000 | 3,948,000 | 2,820,204 | 2,142,028 | 1,689,590 |
| Operating Expenses | 3,643,000 | 2,775,000 | 2,128,739 | 1,676,826 | 1,542,051 |
| Operating Income | 1,979,000 | 1,173,000 | 691,588 | 465,832 | 147,981 |
| Interest Expense | 50,000 | 7,000 | 2,937 | 0 | 0 |
| Other Income | 84,000 | 54,000 | 208,855 | -436,083 | 135,005 |
| Pre-tax Income | 2,013,000 | 1,220,000 | 897,506 | 29,749 | 282,986 |
| Income Tax | 734,000 | 435,000 | 287,324 | -34,038 | 127,112 |
| Net Income Continuous | 1,279,000 | 785,000 | 610,182 | 63,787 | 155,874 |
| Net Income | $1,279,000 | $785,000 | $562,527 | $63,787 | $150,236 |
| EPS Basic Total Ops | 1.21 | 0.74 | 0.54 | 0.06 | 0.15 |
| EPS Basic Continuous Ops | 1.21 | 0.74 | 0.59 | 0.06 | 0.15 |
| EPS Diluted Total Ops | 1.18 | 0.73 | 0.53 | 0.06 | 0.14 |
| EPS Diluted Continuous Ops | 1.18 | 0.73 | 0.58 | 0.06 | 0.15 |
| EBITDA(a) | $2,349,000 | $1,526,000 | $987,037 | $740,787 | $576,072 |